Drug Trial Radar · NCT07501702
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
34
Actual
Start
May 13, 2026
Primary completion
Mar 2, 2029
Study completion Mar 2, 2029
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Mar 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Conditions
- Myasthenia Gravis, Generalized
Interventions
PovetaciceptDrug
Solution for Subcutaneous Injection.
PlaceboDrug
Solution for Subcutaneous Injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in Total Immunoglobulin G (IgG)Time frame: Baseline and At Week 12
- Safety and Tolerability as Assessed by Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: From Baseline Up to Week 116
Locations
31 sites in 5 countries. Site status is shown where the registry gives one.
Tri Valley Neurology Medical Associates Inc.
Mission Hills, California
Neurology Offices
Boca Raton, Florida
SFM Clinical Reseach, LLC
Boca Raton, Florida
Homestead Associates in Research
Homestead, Florida
UF Health Jacksonville Respiratory Therapy (PFT and DLCO)
Jacksonville, Florida
Y & L Advance Health Care, Inc D/B/A Elite Clinical Research - Neurology
Miami, Florida
Quantix Research
Miami, Florida
USF Carol and Frank Morsani Center for Advanced Healthcare
Tampa, Florida
Patient Care Clinical Research, LLC
Snellville, Georgia
Hawaii Pacific Neuroscience
Honolulu, Hawaii
HSHS Medical Group - St. Elizabeth's Hospital
O'Fallon, Illinois
Las Vegas Neurology Center
Las Vegas, Nevada
Univ of NC Chapel Hill, Neurology
Chapel Hill, North Carolina
Clinical Trials of South Carolina - Neurology
Charleston, South Carolina
Ut Erlanger Neurology
Chattanooga, Tennessee
Nerve and Muscle Center of Texas - Neurology
Houston, Texas
Texas Institute for Neurological Disorders
Sherman, Texas
Neurology Care Clinic
Waxahachie, Texas
Eastern Health - Box Hill Hospital
Box Hill, Australia
MICS Centrum Medyczne Bydgoszcz
Bydgoszcz, Poland
Neurologia Slaska Centrum Medyczne
Katowice, Poland
Clinical Research Center Sp. z o.o., Medic-R Sp. K.
Poznan, Poland
NZOZ NEURO-KARD Ilkowski i Partnerzy Sp. Partnerska Lekarzy
Poznan, Poland
Twoja Przychodnia Poznanskie Centrum Medyczne Sp. z o. o.
Poznan, Poland
Centrum Medyczne Neuroprotect
Warsaw, Poland
ETG Neuroscience
Warsaw, Poland
Istanbul University Medical Faculty
Fatih, Turkey (Türkiye)
Kocaeli University Medical Faculty
Kocaeli, Turkey (Türkiye)
University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital
Birmingham, United Kingdom
St. George's University Hospital
London, United Kingdom
Northern Care Alliance NHS Foundation Trust - Salford Royal Hospital
Salford, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.